The Role of Protein C Inhibitor in Human Reproduction

Francisco España; Silvia Navarro; Pilar Medina; Esther Zorio; Amparo Estellés

doi:10.1055/s-2006-958460

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2007; 33(1): 041-045
DOI: 10.1055/s-2006-958460

The Role of Protein C Inhibitor in Human Reproduction

Francisco España¹ , Silvia Navarro¹ , Pilar Medina¹ , Esther Zorio¹ , Amparo Estellés¹

¹Hospital Universitario La Fe, Centro de Investigación, Valencia, Spain

Abstract

ABSTRACT

Protein C inhibitor (PCI) is a heparin-dependent serine protease inhibitor found in human plasma, urine, and other body fluids. In blood plasma, PCI is present at ~0.08 μM and inactivates activated protein C and other coagulation and fibrinolytic enzymes. In seminal plasma, PCI is present at 2.2 to 3.7 μM. The main sources of seminal PCI are the seminal vesicles, where it remains fully active. Following ejaculation, PCI completely looses its activity in approximately 2 hours, when it partially complexes with prostate-specific antigen, two plasminogen activators (urokinase-type and tissue-type plasminogen activators), and tissue kallikrein. PCI is also present in an active form in follicular fluid at ~0.1 μM. Purified functionally active human blood plasma-derived as well as inactive semen-derived PCI inhibited both binding and penetration of zona-free hamster oocytes by human sperm. The binding inhibition by PCI was dose dependent. A concentration of 0.04 μM PCI (~100-fold lower than that present in seminal plasma) inhibited 50% of the binding and penetration ability. Given that capacitated sperm used for in vitro fertilization usually contains more than 0.05 μM of PCI, fertilization rates might be significantly reduced. All of these data suggest that PCI is involved in human reproduction at several steps, including the fertilization process.

KEYWORDS

Protein C inhibitor - fertilization - sperm - seminal plasma - plasminogen activators

Full Text

References

REFERENCES

1 España F, Medina P, Navarro S, Zorio E, Estellés A, Aznar J. The multifunctional protein C system. Curr Med Chem Cardiovasc Hematol Agents. 2005; 3 119-131
2 Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor: purification from human plasma and characterization. J Biol Chem. 1983; 258 163-168
3 España F, Berrettini M, Griffin J H. Purification and characterization of plasma protein C inhibitor. Thromb Res. 1989; 55 369-384
4 Heeb M J, Griffin J H. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin. J Biol Chem. 1988; 263 11613-11616
5 Heeb M J, Espana F, Griffin J H. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood. 1989; 73 446-454
6 Heeb M J, España F, Geiger M, Collen D, Stump D, Griffin J H. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem. 1987; 262 15813-15816
7 Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem Tokyo. 1984; 95 187-195
8 España F, Griffin J H. Determination of functional and antigen protein C inhibitor and its complexes with activated protein C in plasma by ELISAs. Thromb Res. 1989; 55 671-682
9 España F, Vicente V, Tabernero D, Scharrer I, Griffin J H. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb Res. 1990; 59 593-608
10 Tabernero D, España F, Vicente V, Estellés A, Gilabert J, Aznar J. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment. Thromb Haemost. 1990; 63 380-382
11 Geiger M, Huber K, Wojta J et al.. Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo. Blood. 1989; 74 722-728
12 España F, Gruber A, Heeb M J, Hanson S R, Harker L A, Griffin J H. In vivo and in vitro complexes of activated protein C with two inhibitors in baboon. Blood. 1991; 77 1754-1760
13 España F, Estellés A, Fernández P J, Gilabert J, Sánchez-Cuenca J, Griffin J H. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen, and blood plasma. Thromb Haemost. 1993; 70 989-994
14 España F, Vicente V, Estellés A et al.. Activation of protein C and complex formation between protein C inhibitor and tissue plasminogen activator during thrombolytic therapy. Fibrinolysis. 1993; 7 308-315
15 Vicente V, España F, Tabernero D, Aznar J, Estellés A, Griffin J H. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever. Blood. 1991; 78 416-422
16 Fernández J A, España F, Gilabert J, Estellés A, Aznar J. Decreased levels of protein C inhibitor during pregnancy and puerperium. Rev Iberoamer Tromb Hemostas. 1991; 4 189-192
17 Alcaraz A, España F, Sánchez-Cuenca J et al.. Activation of the protein C pathway in acute sepsis. Thromb Res. 1995; 79 83-93
18 Geiger M, Priglinger U, Griffin J H, Binder B R. Urinary protein C inhibitor. J Biol Chem. 1991; 266 11851-11857
19 España F, Fink E, Sánchez-Cuenca J, Gilabert J, Estellés A, Witzgall K. Complexes of tissue kallikrein with protein C inhibitor in human semen and urine. Eur J Biochem. 1995; 234 641-649
20 Hayashi T, Nishioka J, Kamada H et al.. Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions. J Thromb Haemost. 2004; 2 949-961
21 España F, Gilabert J, Estellés A, Romeu A, Aznar J, Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res. 1991; 64 309-320
22 España F, Estellés A, Griffin J H, Aznar J. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma. Thromb Haemost. 1991; 65 46-51
23 España F, Snchez-Cuenca J, Vera C D, Estellés A, Gilabert J, Aznar J. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard. J Lab Clin Med. 1993; 122 711-719
24 Smokovitis A, Nokolis N, Alexopoulos C, Alexaki E, Eleftheriou E. Plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition in spermatozoa and seminal plasma of man and various animal species. Effect of plasmin on sperm motility. Fibrinolysis. 1987; 1 253-257
25 Hong C Y, Chiang B N, Huang J J, Wu P. Two plasminogen activators, streptokinase and urokinase, stimulate human sperm motility. Andrologia. 1985; 17 317-322
26 Schill W B. Caffeine and kallikrein-induced stimulation of human sperm motility: a comparative study. Andrologia. 1975; 7 229-236
27 Laurell M, Christensson A, Abrahamsson P A, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest. 1992; 89 1094-1101
28 Odet F, Guyot R, Leduque P, Le Magueresse-Battistoni B. Evidence for similar expression of protein C inhibitor and the urokinase-type plasminogen activator system during mouse testis development. Endocrinology. 2004; 145 1481-1489
29 Deperthes D, Chapdelaine P, Tremblay R R et al.. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim Biophys Acta. 1995; 1245 311-316
30 Kise H, Nishioka J, Kawamura J, Suzuki K. Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor. Eur J Biochem. 1996; 238 88-96
31 Zheng X, Geiger M, Ecke S et al.. Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am J Physiol. 1994; 267 C466-C472
32 Moore A, Penfold L M, Johnson J L, Latchman D S, Moore H D. Human sperm-egg binding is inhibited by peptides corresponding to core region of an acrosomal serine protease inhibitor. Mol Reprod Dev. 1993; 34 280-291
33 Elisen M G, van Kooij R J, Nolte M A et al.. Protein C inhibitor may modulate human sperm-oocyte interactions. Biol Reprod. 1998; 58 670-677
34 Lwaleed B A, Greenfield R, Stewart A, Birch B, Cooper A J. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost. 2004; 92 752-766
35 España F, Sánchez-Cuenca J, Fernández P J et al.. Inhibition of human sperm-zona-free hamster oocyte binding and penetration by protein C inhibitor. Andrologia. 1999; 31 217-223
36 He S, Lin Y L, Liu Y X. Functionally inactive protein C inhibitor in seminal plasma may be associated with infertility. Mol Hum Reprod. 1999; 5 513-519
37 Uhrin P, Dewerchin M, Hilpert M et al.. Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J Clin Invest. 2000; 106 1531-1539
38 Gianotten J, Schimmel A W, Van der Veen F, Lombardi M P, Meijers J C. Absence of mutations in the PCI gene in subfertile men. Mol Hum Reprod. 2004; 10 807-813

Francisco EspañaPh.D.

Hospital Universitario La Fe Centro de Investigación, Av. Campanar

21 46009 Valencia, Spain

Email: espanya_fra@gva.es